GRAND PRAIRIE, Texas — Neos Therapeutics Inc. (NEOS) on Wednesday reported a loss of $15.2 million in its second quarter.
On a per-share basis, the Grand Prairie, Texas-based company said it had a loss of 52 cents.
The pharmaceutical company posted revenue of $11.4 million in the period.
Neos Therapeutics shares have declined 43 percent since the beginning of the year. The stock has declined 15 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NEOS at https://www.zacks.com/ap/NEOS